AME:NYSEAMETEK, Inc. Analysis
Data as of 2026-03-10 - not real-time
$225.07
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The short‑term moving average sits above the longer‑term average, indicating a bullish bias, while the RSI hovers in the mid‑40s, suggesting neutral momentum. However, the MACD histogram is negative and the signal line is bearish, warning of potential short‑term weakness. Volume has been trending upward, supporting the current price above recent support levels. Fundamental momentum: The company posted double‑digit revenue growth and margin expansion in its latest quarter, beating expectations and reinforcing its growth narrative.
Valuation and income: The stock trades at a price‑to‑earnings multiple that exceeds the industry average, and a discounted cash‑flow model places fair value well below the market price, flagging a possible overvaluation. Despite this, the dividend yield remains modest with a low payout ratio, indicating a sustainable income stream. The combination of solid earnings, strong cash generation, and a diversified product portfolio supports a positive longer‑term outlook, albeit with caution on price appreciation.
Valuation and income: The stock trades at a price‑to‑earnings multiple that exceeds the industry average, and a discounted cash‑flow model places fair value well below the market price, flagging a possible overvaluation. Despite this, the dividend yield remains modest with a low payout ratio, indicating a sustainable income stream. The combination of solid earnings, strong cash generation, and a diversified product portfolio supports a positive longer‑term outlook, albeit with caution on price appreciation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram suggests limited upside
- Increasing volume provides support for price stability
- Neutral RSI indicates no clear momentum direction
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Record earnings and double‑digit revenue growth
- Strong operating and free cash flow generation
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Diversified exposure across aerospace, energy, and medical markets
- Continued cash flow strength to fund growth initiatives
- Valuation premium may limit upside but dividend provides steady return
Key Metrics & Analysis
Financial Health
Revenue Growth13.40%
Profit Margin20.00%
P/E Ratio35.2
ROE14.59%
ROA7.88%
Debt/Equity24.19
P/B Ratio4.9
Op. Cash Flow$1.8B
Free Cash Flow$1.3B
Industry P/E29.5
Technical Analysis
TrendBullish
RSI44.8
Support$217.52
Resistance$242.05
MA 20$232.85
MA 50$223.21
MA 200$195.86
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Fair Value$133.12
Target Price$249.18
Upside/Downside10.71%
GradeOvervalued
TypeGrowth
Dividend Yield0.60%
Risk Assessment
Beta0.82
Volatility23.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.